摘要
目的 观察通心络胶囊治疗不稳定性心绞痛 (UAP)的临床疗效和血液流变性变化。方法 将 80例UAP患者随机分为常规治疗组 (对照组 )及常规治疗加通心络组 (治疗组 ) ,疗程为 1个月。结果 1个月后总有效率 :治疗组为 92 .5 % ,对照组为 6 7.5 % (P <0 .0 1) ;治疗组无一例发生心肌梗死 ,对照组有 2例发生心肌梗死 (5 % )。治疗组未发现明显不良反应。结论 在常规治疗基础上加用通心络 ,能更有效地控制心绞痛发作 ,减少心肌梗死发生率。
Objective To observe clinical therapeutic effectiveness of Tongxinluo capsule in treating unstable angina pectoris.Method 80 Cases of unstable angina pectoris were randomly allocated into the control group of normal treatment and treating group (normal treatment combined with Tongxinluo capsule). The therapeutic course was one month.Result After one month total effective ratio is 92.5 per cent in the treating group and 67.5 per cent in the control group (P<0.01).No acute myocardial infraction happened in the treating group. 2 cases had acute myocardial infration in the control group (5%). And the treating group had no obvious adverse reaction. Conclusion Tongxinluo capsule conbined with normal treatment can control angina pectoris effectively and decrease incidence of myocardial infraction.
出处
《中国血液流变学杂志》
CAS
2004年第4期494-496,共3页
Chinese Journal of Hemorheology